Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

sector : Health technology    save search

EYEPOINT SHAREHOLDER ACTION REMINDER
Published: 2023-01-28 (Just crawled : 16:20) - prnewswire.com
EYPT | News | $4.72 5.12% 4.87% 98K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist


Biologics CDMO Secondary Packaging Global Market Report 2022: Sector to Generate $3.62 Billion by 2030
Published: 2023-01-28 (Crawled : 12:20) - prnewswire.com
ABBV | News | $146.28 -0.76% 0.06% 4.6M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
TMO | News | $573.63 -0.65% -0.03% 1.1M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

global report market
Insights on the Local Anesthesia Drugs Global Market to 2027 - by Drug Type, Mode of Administration, Distribution Channel and Region
Published: 2023-01-28 (Crawled : 12:20) - prnewswire.com
ENDPQ | News | $0.1007 0 twitter stocktwits trandingview |
n/a
| Email alert Add to watchlist
ENDP | News | $0.2926 -9.6% twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
BAX | News | $46.0 -0.35% 0.0% 2.9M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

drug global distribution market
Flexible Display Global Market Report 2022: by Display Type, Substrate Material, Form Factor, Application and Region
Published: 2023-01-28 (Crawled : 12:20) - prnewswire.com
AUOTY | News | $5.45 0 twitter stocktwits trandingview |
Manufacturing
| Email alert Add to watchlist
GLW | News | $36.8 1.02% -0.49% 4.5M twitter stocktwits trandingview |
Electronic Technology
| Email alert Add to watchlist
PHG | News | $16.99 0.59% 0.35% 2.3M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

global report application market
ROSEN, A RESPECTED AND LEADING FIRM, Encourages National Realty Investment Advisors LLC Investors to Secure Counsel Before Important Deadline in Securities Class Action - NRIA
Published: 2023-01-27 (Crawled : 00:20) - prnewswire.com
BLRX | News | $0.64 -1.92% -1.95% 300K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
GSX | News | $27.08 0% twitter stocktwits trandingview |
Technology Services
| Email alert Add to watchlist

deadline
Inhibikase Therapeutics Announces Closing of $10 Million Concurrent Registered Direct Offering and Private Placement Priced At a Premium to Market Under Nasdaq Rules
Published: 2023-01-27 (Crawled : 23:00) - biospace.com/
IKT | News 0 d | $0.69 -2.82% -2.9% 420K twitter stocktwits trandingview |
Health Technology
| | O: -2.82% H: 0.0% C: 0.0%

offering nasdaq therapeutics direct market
Precigen Announces Closing of Public Offering of Common Stock
Published: 2023-01-27 (Crawled : 23:00) - biospace.com/
PGEN | News 0 d | $1.64 1.23% 1.22% 4.3M twitter stocktwits trandingview |
Health Technology
| | O: 1.85% H: 0.0% C: 0.0%

offering
Pliant Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Published: 2023-01-27 (Crawled : 22:00) - globenewswire.com
PLRX | News M 0 d | $34.87 -3.83% -3.99% 1M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

offering therapeutics
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-01-27 (Crawled : 22:00) - jaguarhealth.gcs-web.com
JAGX | News | $4.69 3.99% 3.84% 310K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

nasdaq health grants employee
TWST Investors Have Opportunity to Lead Twist Bioscience Corporation Securities Fraud Lawsuit
Published: 2023-01-27 (Crawled : 22:00) - prnewswire.com
TWST | News | $29.18 4.36% 4.18% 740K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
NEO | News | $11.51 1.68% 1.65% 440K twitter stocktwits trandingview |
Health Services
| Email alert Add to watchlist
BLRX | News | $0.64 -1.92% -1.95% 300K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

corporation bioscience
Nemaura Medical Announces Pricing of Approximately $8.4 Million Registered Direct Offering and Concurrent Private Placement
Published: 2023-01-27 (Crawled : 22:00) - biospace.com/
NMRD | News 0 d | $1.65 -42.31% -73.33% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: -34.27% H: 0.0% C: 0.0%

offering medical direct
Achieve Life Sciences Announces Granting of New Hire Inducement Award
Published: 2023-01-27 (Crawled : 22:00) - globenewswire.com
ACHV | News A | $4.96 5.31% 5.04% 71K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

award sciences life
Immusoft Awarded $8M in Funding from the California Institute for Regenerative Medicine (CIRM) for MPS I Clinical Program
Published: 2023-01-27 (Crawled : 21:00) - biospace.com/
TAK | News | $16.03 -0.43% 0.0% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.43% H: 0.0% C: 0.0%

california for program funding
ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm - BLRX
Published: 2023-01-27 (Crawled : 21:00) - prnewswire.com
BLRX | News | $0.64 -1.92% -1.95% 300K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

deadline
Legend Biotech Announces Phase 3 CARTITUDE-4 Study of CARVYKTI® (ciltacabtagene autoleucel) Has Met Its Primary Endpoint in the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Published: 2023-01-27 (Crawled : 21:00) - biospace.com/
LEGN | News | $52.71 -2.1% -2.14% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 2.98% H: 0.0% C: 0.0%

carvykti treatment biotech study
United States Home Healthcare Market Size, Share & Trends Analysis Report 2022: A $253.4 Billion Industry by 2030 - Growing Incidences of Chronic Diseases and Increasing Geriatric Population
Published: 2023-01-27 (Crawled : 21:00) - prnewswire.com
MDT | News | $82.58 0.9% 0.47% 4.8M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
SNDA | News P | $14.75 1.15% 83 twitter stocktwits trandingview |
n/a
| Email alert Add to watchlist
BKD | News | $2.95 2.43% -1.36% 6.7M twitter stocktwits trandingview |
Health Services
| Email alert Add to watchlist
CSU | News | $33.54 0% twitter stocktwits trandingview |
Health Services
| Email alert Add to watchlist
DVCR | News | $10.09 0% twitter stocktwits trandingview |
Health Care and Social Assistan...
| Email alert Add to watchlist
BDX | News A | $251.82 1.08% 0.0% 1.2M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
BAX | News | $46.0 -0.35% 0.0% 2.9M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

trends report growing home market
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Gaotu Techedu Inc. f/k/a GSX Techedu Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm - GOTU, GSX
Published: 2023-01-27 (Crawled : 21:00) - prnewswire.com
BLRX | News | $0.64 -1.92% -1.95% 300K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
GSX | News | $27.08 0% twitter stocktwits trandingview |
Technology Services
| Email alert Add to watchlist

deadline initiated
Janssen Announces Unblinding of Phase 3 CARTITUDE-4 Study of CARVYKTI® (cilta-cel) as Primary Endpoint Met in Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Published: 2023-01-27 (Crawled : 21:00) - biospace.com/
JNJ | News 3 d | $168.23 -0.39% -0.04% 6M twitter stocktwits trandingview |
Health Technology
| | O: -0.5% H: 0.0% C: 0.0%

carvykti treatment study
Global STAT3 Inhibitors Market & Clinical Trials Outlook 2028: Insight and Analysis on Over 30 Drugs and 20 Companies
Published: 2023-01-27 (Crawled : 20:00) - prnewswire.com
INCY | News F | $85.66 -0.41% -0.41% 930K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

trials global companies market
U.S. FDA Approves Jaypirca™ (pirtobrutinib), the First and Only Non-Covalent (Reversible) BTK Inhibitor, for Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma After at Least Two Lines of Systemic Therapy, Including a BTK Inhibitor
Published: 2023-01-27 (Crawled : 20:00) - biospace.com/
LLY | News | $342.1 -1.7% 0.12% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.54% H: 0.0% C: 0.0%

fda for
Gainers vs Losers
66% 34%

Top 10 Gainers

Your saved searches
Save your searches and get alerts when important news are released.